28 research outputs found
Multi-ancestry genome-wide association meta-analysis of Parkinsonâs disease
\ua9 2023, This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply. Although over 90 independent risk variants have been identified for Parkinsonâs disease using genome-wide association studies, most studies have been performed in just one population at a time. Here we performed a large-scale multi-ancestry meta-analysis of Parkinsonâs disease with 49,049 cases, 18,785 proxy cases and 2,458,063 controls including individuals of European, East Asian, Latin American and African ancestry. In a meta-analysis, we identified 78 independent genome-wide significant loci, including 12 potentially novel loci (MTF2, PIK3CA, ADD1, SYBU, IRS2, USP8, PIGL, FASN, MYLK2, USP25, EP300 and PPP6R2) and fine-mapped 6 putative causal variants at 6 known PD loci. By combining our results with publicly available eQTL data, we identified 25 putative risk genes in these novel loci whose expression is associated with PD risk. This work lays the groundwork for future efforts aimed at identifying PD loci in non-European populations
Genetic determinants of daytime napping and effects on cardiometabolic health
This is the final version. Available from Nature Research via the DOI in this record.âŻSummary GWAS statistics are publicly available at The Sleep Disorder Knowledge Portal
webpage: http://sleepdisordergenetics.org/.Daytime napping is a common, heritable behavior, but its genetic basis and causal relationship with cardiometabolic health remain unclear. Here, we perform a genome-wide association study of self-reported daytime napping in the UK Biobank (n = 452,633) and identify 123 loci of which 61 replicate in the 23andMe research cohort (n = 541,333). Findings include missense variants in established drug targets for sleep disorders (HCRTR1, HCRTR2), genes with roles in arousal (TRPC6, PNOC), and genes suggesting an obesity-hypersomnolence pathway (PNOC, PATJ). Association signals are concordant with accelerometer-measured daytime inactivity duration and 33 loci colocalize with loci for other sleep phenotypes. Cluster analysis identifies three distinct clusters of nap-promoting mechanisms with heterogeneous associations with cardiometabolic outcomes. Mendelian randomization shows potential causal links between more frequent daytime napping and higher blood pressure and waist circumference.National Institute of HealthNational Institute of HealthNational Institute of HealthNational Institute of HealthNational Institute of HealthMGH Research Scholar Fund, Academy of FinlandMedical Research CouncilSpanish Government of Investigation, Development and InnovationSeneca FoundationNIDDKInstrumentarium Science FoundationYrjö Jahnsson Foundatio
The Parkinsonâs Disease Mendelian Randomization Research Portal
Mendelian randomization is
a method for exploring observational associations to find
evidence of causality. To apply Mendelian randomization between
risk factors/phenotypic traits (exposures) and PD in a
large, unbiased manner, and to create a public resource
for research. We observed evidence for causal associations
between 12 exposures and risk of PD. Of these, nine
were effects related to increasing adiposity and
decreasing risk of PD. The remaining top three exposures
that affected PD risk were tea drinking, time spent
watching television, and forced vital capacity, but these
may have been biased and were less convincing. Other
exposures at nominal statistical significance included
inverse effects of smoking and alcohol. We present a new platform which offers
Mendelian randomization analyses for a total of 5,839
genome-wide association studies versus the largest
PD genome-wide association studies available
(https://pdgenetics.shinyapps.io/MRportal/). Alongside,
we report further evidence to support a causal
role for adiposity on lowering the risk of PD. © 2019
The Authors. Movement Disorders published by Wiley
Periodicals, Inc. on behalf of International Parkinson
and Movement Disorder Society.AJN reports grants from Parkinsonâs UK, Barts Charity, Leonard Wolfson Experimental Neurology Centre, UCL
Movement Disorders Centre and the Virginia Kieley Benefaction; honoraria or consultancy fees from Britannia,
Global Kinetics Corporation, Profile Pharmaceuticals, Guide point, Biogen and Roche. KH and DAH are employees
of 23andMe and hold stock or stock options in 23andMe. DAL reports grants from the Medical Research Council,
numerous charitable funders,Medtronic and Roche. ZG-O reports consultancy fees from Inceptions Sciences,Idorsia,
Denali, Lysosomal Therapeutics inc. HM reports reports consultancy from Biogen, UCB, Abbvie, Denali, Biohaven;
lecture fees/honoraria from Biogen, UCB,C4X Discovery, GE-Healthcare, Welcome Trust, Movement Disorders Society;
Research Grants from Parkinsonâs UK, Cure Parkinsonâs Trust, PSP Association, CBD Solutions, Drake Foundation,
Medical Research Council. Dr Morris is a co-applicanton a patent application related to C9ORF72
(PCT/GB2012/052140)
Common Variant Burden Contributes to the Familial Aggregation of Migraine in 1,589 Families
© 2018 Elsevier Inc. Complex traits, including migraine, often aggregate in families, but the underlying genetic architecture behind this is not well understood. The aggregation could be explained by rare, penetrant variants that segregate according to Mendelian inheritance or by the sufficient polygenic accumulation of common variants, each with an individually small effect, or a combination of the two hypotheses. In 8,319 individuals across 1,589 migraine families, we calculated migraine polygenic risk scores (PRS) and found a significantly higher common variant burden in familial cases (n = 5,317, OR = 1.76, 95% CI = 1.71â1.81, p = 1.7 Ă 10â109) compared to population cases from the FINRISK cohort (n = 1,101, OR = 1.32, 95% CI = 1.25â1.38, p = 7.2 Ă 10â17). The PRS explained 1.6% of the phenotypic variance in the population cases and 3.5% in the familial cases (including 2.9% for migraine without aura, 5.5% for migraine with typical aura, and 8.2% for hemiplegic migraine). The results demonstrate a significant contribution of common polygenic variation to the familial aggregation of migraine. Gormley et al. use polygenic risk scores to show that common variation, captured by genome-wide association studies, in combination contributes to the aggregation of migraine in families. The results may have similar implications for other complex traits in general
pH and proton sensor GPR65 determine susceptibility to atopic dermatitis
pH sensing by GPR65 regulates various inflammatory conditions, but its role in skin remains unknown. In this study, we performed a phenome-wide association study and report that the T allele of GPR65-intronic single-nucleotide polymorphism rs8005161, which reduces GPR65 signaling, showed a significant association with atopic dermatitis, in addition to inflammatory bowel diseases and asthma, as previously reported. Consistent with this genetic association in humans, we show that deficiency of GPR65 in mice resulted in markedly exacerbated disease in the MC903 experimental model of atopic dermatitis. Deficiency of GPR65 also increased neutrophil migration in vitro. Moreover, GPR65 deficiency in mice resulted in higher expression of the inflammatory cytokine TNF-α by T cells. In humans, CD4+ T cells from rs8005161 heterozygous individuals expressed higher levels of TNF-α after PMA/ionomycin stimulation, particularly under pH 6 conditions. pH sensing by GPR65 appears to be important for regulating the pathogenesis of atopic dermatitis